RxDoctor Payments DataLook up a doctor →

Lacie Theis

Psychiatric/Mental Health · Waverly, IANPI 1871105916

Payments from drug & device makers

$9,354in general payments, 2019–2025

Across 710 payments — averaging $13.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$1K
  • Alkermes, Inc.$969
  • Johnson & Johnson$900
  • Otsuka America Pharmaceutical, Inc.$802
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$802
  • Teva Pharmaceuticals USA, Inc.$728
  • plus $4K from 13 others

What the payments were for

  • Food & beverage$9,07597%
  • Education$2793%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,354 in reported general payments places this provider in the 95th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$10,882
Medicare patients
32
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate25$187,403
VraylarCariprazine Hcl24$34,909
Aripiprazole33$2,085
Desvenlafaxine Succinate ErDesvenlafaxine Succinate25$1,953
Lurasidone Hcl12$1,629
Bupropion XlBupropion Hcl44$1,357
Vilazodone Hcl13$1,241
Buspirone Hcl104$923
Quetiapine Fumarate75$871
Perphenazine13$784
Duloxetine Hcl38$626
Hydroxyzine Pamoate47$570
Risperidone38$507
Methylphenidate Hcl16$493
Trazodone Hcl83$493

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$1,402$187,40325 claims
AbbVieVraylar$712$34,90924 claims
Almatica Pharma LLCSertraline Hcl$128$8623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Waverly

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →